MedTrace Logo

Middle-Ear Implant With MET V Transducer (Aka MET V System)

NCT01529333 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2012-02-08

No results posted yet for this study

Summary

The purpose and objective of this study is to evaluate the safety and efficacy of the MET V System for the treatment of individuals with mixed hearing loss.

Conditions

  • Mixed Conductive and Sensorineural Hearing Loss, Bilateral

Interventions

DEVICE

Middle Ear Implant with MET V Transducer

The MET V System is indicated for use in addressing the amplification needs of adults, 18 years of age and older, who have mixed hearing loss.

Sponsors & Collaborators

  • Otologics LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-07-31
Completion
2012-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01529333 on ClinicalTrials.gov